Drug Resistance Updates (DRU) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics. Elsevier is the publisher of this esteemed journal. The P-ISSN assigned to Drug Resistance Updates is 1368-7646 and its abbreviated form is Drug Resist Updat.
Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.
Journal title | Drug Resistance Updates (DRU) |
Abbreviation | Drug Resist Updat |
Print ISSN | 1368-7646 |
Online ISSN | 1532-2084 |
Publisher Name | Elsevier |
Editor-in-chief | Zhe-Sheng Chen, MD, PhD |
Subject Category | Pharmacology, Toxicology and Pharmaceutics |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Drug Resistance Updates Journal is Drug Resist Updat.
The Ranking of the Journal in 2024 is 330. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 24.3. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 4.391. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 125. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Drug Resist Updat |
Access type | Hybrid |
Impact Factor | 24.3 |
SJR | 4.391 |
SNIP | 3.535 |
Ranking | 330 |
CiteScore | 34.8 |
H-Index | 125 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is 5260 USD, 4800 EUR, 4210 GBP
Call for paper : The Journal invites original research contributions for consideration of publication in Drug Resistance Updates journal.
Journal seeking submissions in the broad areas of Pharmacology, Toxicology and Pharmaceutics that align with journal's focus on Pharmacology, Toxicology and Pharmaceutics.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Drug Resistance Updates involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 24.3.
The Ranking of the Journal is 330.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Drug Resistance Updates (DRU) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics. Elsevier is the publisher of this esteemed journal.
Yes, Drug Resistance Updates is a open access (Hybrid) journal.